Dreem

Qantas monitors brainwaves of pilots and passengers to test 19.5‑hour flight from NY to Sydney

by

Mon­i­tor­ing brain­waves via dreem wer­able device (Qan­tas)

_______________

Qan­tas’ first 19.5‑hour research flight from New York to Syd­ney takes off (Nine News):

“Qan­tas CEO Alan Joyce, who today is in New York for the research flight, told Today Show via a live cross that he will be select­ing an air­craft for the mam­moth job by the year’s end, in line with a pre­vi­ous time-line.

“The flight is going to be ground-break­ing, as you said. We’ve got 19 hours — we’ve got a lot of sci­en­tists and we’re look­ing at dif­fer­ent ways of mak­ing the oper­a­tion actu­al­ly great for our pas­sen­gers,” Joyce said. [Read more…] about Qan­tas mon­i­tors brain­waves of pilots and pas­sen­gers to test 19.5‑hour flight from NY to Sydney

Update: 200 common prescription medications increase depression risk

by

___

Dear read­er,

Time for Sharp­Brains e‑newsletter.

It’s been a busy month, once again bring­ing to the fore­front the lim­i­ta­tions of our cur­rent health­care sys­tem and, on the pos­i­tive side, the grow­ing oppor­tu­ni­ties to improve Brain Health and Men­tal Health for all, if we pay atten­tion to (and act on) lat­est research, think­ing and tools.

New research:

New thinking:

New tools:

 

Final­ly, we invite you to tease your mind with these four opti­cal illu­sions. Sur­pris­ing, aren’t they?

Have a great month of July,

 

The Sharp­Brains Team

Sleep-focused neurotech firm Dreem raises $35M from Johnson&Johnson Innovation and Bpifrance

by

___

Dreem Announces $35 Mil­lion Financ­ing from lead investors John­son & John­son Inno­va­tion and Bpifrance (press release):

“Dreem, a neu­rotech­nol­o­gy com­pa­ny, today announced the clos­ing of a new round of fund­ing, rais­ing $35 mil­lion USD to rapid­ly accel­er­ate prod­uct devel­op­ment, invest in strate­gic research and devel­op­ment, and advance the future of sleep tech­nol­o­gy. Last year, Dreem intro­duced a com­pre­hen­sive solu­tion to address a suite of sleep prob­lems and [Read more…] about Sleep-focused neu­rotech firm Dreem rais­es $35M from John­son&John­son Inno­va­tion and Bpifrance

Neurotech start-up Rythm raises $11 million more to develop and commercialize sleep-monitoring headband Dreem

by

—

Dreem machine: Rythm rais­es $11 mil­lion and launch­es $500 sleep-mon­i­tor­ing head­band (Ven­ture­Beat)

“Found­ed out of France in 2014, Rythm is now based in San Fran­cis­co, where it has been work­ing toward bring­ing its Dreem machine head­band to market…In a nut­shell, Rythm touts itself as a neu­rotech­nol­o­gy com­pa­ny that’s set­ting out to “enhance” your sleep, [Read more…] about Neu­rotech start-up Rythm rais­es $11 mil­lion more to devel­op and com­mer­cial­ize sleep-mon­i­tor­ing head­band Dreem

French neurotech start-up Rythm raises $11m to help improve sleep quality

by

Rythm dreem—–

Rythm rais­es $11M to pur­sue sleep-improv­ing neu­rotech­nol­o­gy (TechCrunch):

“French start­up Rythm, which makes a tech-infused head­set it claims improves sleep qual­i­ty, announced Tues­day that it’s raised over $11 mil­lion from pri­vate investors and pub­lic grants [Read more…] about French neu­rotech start-up Rythm rais­es $11m to help improve sleep quality